93 Shennecossett Rd.
Groton, CT 06340
Phone: 860-906-7302
Website: https://virtustherapeutics.com/
Email: virtusadm@virtustherapeutics.com
General Information:
Virtus Therapeutics (C-corp) is focused on the development of the first treatment for pantothenate kinase-associated neurodegeneration (PKAN) using small molecule activators.
Research Activities:
– Evaluate the activity of VTACs in cell-based assays
– Select advanced derivatives of VTACs using biochemical, structural and cell biological assays.
– Evaluate the activity of VTACs in animal models of PKAN